Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 7
Submit an article Journal homepage
185
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Systemic mastocytosis and lymphoplasmacytic lymphoma: an unusual and intriguing form of SM-AHN

Arturo Bonomettia Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3258-0727
ORCID Icon,
Emanuela Boverib Unit of Anatomic Pathology, IRCCS San Matteo Foundation, Pavia, Italy
,
Marzia Varettonic Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy
,
Andrea Ripamontia Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy
,
Sara Fraticellia Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy
,
Marco Lucionib Unit of Anatomic Pathology, IRCCS San Matteo Foundation, Pavia, Italy
,
Silvia Zibellinic Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy
,
Chiara Elenac Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy
,
Daniela Pietrac Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy
,
Luca Arcainic Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, ItalyORCID Iconhttps://orcid.org/0000-0002-9504-991X
ORCID Icon &
Marco Paullia Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy
 show all
Pages 1782-1785 | Received 13 Oct 2020, Accepted 26 Jan 2021, Published online: 14 Feb 2021

References

  • Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420–1427.
  • Pardanani A, Lim K-H, Lasho TL, et al. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Blood. 2009;114(18):3769–3772.
  • Escribano L, Pérez de Oteyza J, Núñez R, et al. Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma. Leuk Res. 2002;26(11):1043–1046.
  • Varettoni M, Zibellini S, Defrancesco I, et al. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. Haematologica. 2017;102(12):2077–2085.
  • Varettoni M, Boveri E, Zibellini S, et al. Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: a multicentric study of the Rete Ematologica Lombarda (REL) network. Am J Hematol. 2019;94(11):1193–1199.
  • Lemal R, Poulain S, Ledoux Pilon A, et al. Mast cell density and its clinical relevance in Waldenstrom's macroglobulinemia. Blood. 2017;130(Suppl 1):4028.
  • Horny HP, Sotlar K, Valent P. Systemic mastocytosis associated with lymphoproliferative disorders (SM-AHNMD). In Anagnostou D, Matutes E, editors. Bone marrow lymphoid infiltrates. London: Springer-Verlag; 2012. p. 271–279.
  • Jahangiri S, Mahesh S. Hepatosplenic gamma-delta T-cell lymphoma presenting with disseminated intravascular coagulation and coexistent systemic mastocytosis. Clin Adv Hematol Oncol. 2010;8(10):690–694.
  • Gerbaulet A, Wickenhauser C, Scholten J, et al. Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active KIT. Blood. 2011;117(6):2012–2021.
  • Merluzzi S, Frossi B, Gri G, et al. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells. Blood. 2010;115(14):2810–2817.
  • Tournilhac O, Santos DD, Xu L, et al. Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling. Ann Oncol. 2006;17(8):1275–1282.
  • Kastritis E, Leblond V, Dimopoulos MA, ESMO Guidelines Committee, et al. Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv41–iv50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.